Expression of Concern: Antitumor Activity of Sorafenib in Human Cancer Cell Lines with Acquired Resistance to EGFR and VEGFR Tyrosine Kinase Inhibitors

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Expression of Concern
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6459487/
https://www.ncbi.nlm.nih.gov/pubmed/30973909
http://dx.doi.org/10.1371/journal.pone.0215109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6459487/
https://www.ncbi.nlm.nih.gov/pubmed/30973909
http://dx.doi.org/10.1371/journal.pone.0215109

Ejemplares similares